pharmaceutical investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
pharmaceutical investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
pharmaceutical investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse